Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: May 25, 2026
Back to directoryAI-driven precision medicine platform for analyzing complex genomic, radiomic, and multimodal healthcare data.
Labs and health systems that need standardized analytics for precision oncology, rare disease, and multimodal data workflows.
Compare within workflow: Precision medicine and data · comparison shortlist · source index
product-specific source-backed lens: These product-specific signals summarize what the cited sources imply before treating SOPHiA GENETICS as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm the exact SOPHiA DDM module, Dx-mode status, IVDR claim, local lab validation path, and whether the workflow is diagnostic, research, or exploratory before clinical use. |
|---|---|
| Privacy | Review data-protection flyers, hosting model, anonymization, sample control, cross-institution insight sharing, HIPAA/GDPR commitments, and the customer agreement for genomic or imaging data. |
| Evidence | Validate the assay, scanner, sequencing, and module performance against the lab's specimen type, disease area, population, and local quality-management requirements. |
| Workflow | Map sample preparation, sequencing or imaging, data upload, interpretation, LIMS/EHR transfer, clinician review, and exception handling before relying on outputs. |
SOPHiA GENETICS describes SOPHiA DDM as an AI platform for precision medicine spanning genomic, radiomic, and multimodal data, with diagnostic-mode and data-protection distinctions to verify.
Not for: Patient-specific treatment decisions without lab validation, regulatory review, and clinician interpretation.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
AI-enabled precision medicine platform spanning molecular testing, multimodal data, clinical assistants, care pathways, imaging insights, and trial matching.
Guardant Health AI and machine-learning portfolio for precision oncology data and multimodal real-world evidence workflows.